Implantica AG logo

Implantica AG (IMP.A.SDB)

Market Closed
XSTO XSTO
kr
kr
- Market Cap
- P/E Ratio
- Div Yield
- Volume
- Eps
kr
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track IMP.A.SDB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

IMP.A.SDB is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

IMP.A.SDB Chart

Implantica AG (IMP.A.SDB) FAQ

What is the stock price today?

The current price is kr0.00.

On which exchange is it traded?

Implantica AG is listed on XSTO.

What is its stock symbol?

The ticker symbol is IMP.A.SDB.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Implantica AG ever had a stock split?

No, there has never been a stock split.

Implantica AG Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Dr. Peter Forsell CEO
XSTO Exchange
- ISIN
Liechtenstein Country
49 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Implantica AG is a pioneering firm based in Vaduz, Liechtenstein, specializing in the research, development, commercialization, and sale of medical implants. Established in 2015, the company excels in creating innovative medical devices aimed at improving patient outcomes across various health conditions. Its mission revolves around enhancing the quality of life through revolutionary implants that offer diagnostic, monitoring, and treatment solutions from within the body. Implantica AG has quickly positioned itself as a leader in the medical implant industry by focusing on addressing unmet medical needs.

Products and Services

  • RefluxStop™: A passive, CE-marked implant designed to prevent gastroesophageal reflux disease (GERD). This device functions without requiring external manipulation, offering a revolutionary approach to managing this widespread condition.
  • e-InVivo™: This series of sensor implants is engineered to monitor various health parameters within the body, providing key diagnostic information. It promises to control treatment remotely, marking a significant step towards personalized medicine.
  • Wireless Energizing Platform: An innovative platform that powers the company's implants wirelessly, eliminating the need for cables and improving patient comfort and mobility.
  • AppetiteControl™: An implant aimed at treating obesity by controlling the patient's appetite. This device represents a novel approach to weight management, potentially reducing the need for more invasive surgical interventions.
  • UriControl™: A remote-controlled artificial urinary sphincter designed to address urinary incontinence in both men and women, offering a dignified solution to a widespread and often debilitating condition.
  • UriRestor™: This device is tailored for spinal cord injury and multiple sclerosis patients, allowing them to urinate on demand via a remote control. Utilizing the company's wireless platform, it provides significant autonomy and improves quality of life.
  • PotencyFlow™: A treatment solution for erectile dysfunction, providing a discreet and effective remedy for this common but seldom-discussed condition.
  • StomaRestore™: An ingenious solution aimed at eliminating the need for stoma bags, significantly improving the lives of individuals with ostomies.
  • RectalRestore™: Designed to treat fecal incontinence, this device offers hope to those suffering from this challenging and often isolating condition.
  • AneurysmControl™: A groundbreaking device for the treatment of aneurysms, providing a minimally invasive solution to a potentially life-threatening condition.

Contact Information

Address: Aeulestrasse 45
Phone: -